Global Vascular Closure Device Market Size By Type (Passive Approximators, Active Approximators), By Application (Interventional Cardiology, Interventional Radiology/Vascular Surgery), By Region, And...

lobal Vascular Closure Device Market Report Description

The Global Vascular Closure Device Market was valued at USD 1.2 billion in 2023 and is projected to surpass USD 2.3 billion by 2031, expanding at a CAGR of 8.4% during the forecast period of 2023–2031. The market is witnessing growth due to the rising volume of cardiovascular procedures, increasing demand for minimally invasive surgeries, and technological advancements in vascular closure devices. These devices play a critical role in achieving hemostasis following catheterization procedures, offering quicker recovery, reduced hospital stays, and lower complication rates.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

The global burden of cardiovascular conditions like coronary artery disease, stroke, and peripheral artery disease is escalating. This has led to an increased number of interventional procedures, directly boosting the demand for vascular closure devices (VCDs).

2. Growing Preference for Minimally Invasive Procedures:

VCDs offer an efficient and less painful alternative to traditional manual compression techniques. Their ability to reduce time to hemostasis and ambulation makes them increasingly preferred in both inpatient and outpatient settings.

3. Technological Advancements:

Continuous innovation in VCD designs—such as absorbable devices and clip-based systems—has enhanced device safety, ease of use, and efficacy, encouraging wider adoption.

Restraints:

1. High Device Costs and Reimbursement Limitations:

Despite their clinical benefits, vascular closure devices are significantly more expensive than manual compression. Reimbursement issues in certain regions further hamper market penetration.

2. Risk of Vascular Complications:

Improper deployment or patient-specific anatomical challenges can sometimes lead to complications like infection, vessel damage, or hematoma formation, restraining the widespread adoption of VCDs.

Opportunity:

1. Expansion in Emerging Markets:

With the growing penetration of healthcare infrastructure in Asia-Pacific, Latin America, and Africa, the vascular closure device market is poised for expansion due to rising procedure volumes and improved access to advanced medical technologies.

2. Increasing Adoption of Ambulatory Surgical Centers (ASCs):

The shift toward outpatient cardiovascular procedures is bolstering the demand for fast-acting, reliable closure solutions that allow for same-day discharge, presenting a significant opportunity for VCD manufacturers.

Market by System Type Insights:

The Passive Approximators segment held the largest share in 2023, driven by its cost-effectiveness and ease of use. However, Active Approximators, which include suture-based and clip-based devices, are expected to witness the fastest growth during the forecast period due to enhanced safety profiles and growing acceptance in high-risk patient groups.

Market by End-use Insights:

The Hospitals segment emerged as the leading end-use segment, accounting for more than 50% of the market share in 2023. The preference for hospital-based interventional procedures is high due to the availability of trained personnel and advanced imaging facilities. However, Ambulatory Surgical Centers (ASCs) are expected to grow rapidly due to cost advantages and shorter patient stays.

Market by Regional Insights:

North America dominated the global vascular closure device market in 2023, driven by high cardiovascular procedure volumes, favorable reimbursement policies, and the strong presence of leading manufacturers. Asia-Pacific is projected to register the fastest growth through 2031, supported by increasing healthcare investments, an aging population, and rising awareness regarding vascular health.

Competitive Scenario:

Prominent companies operating in the market include:

Abbott Laboratories

Terumo Corporation

Cardinal Health

Medtronic plc

Teleflex Incorporated

Morris Innovative, Inc.

Merit Medical Systems

Vasorum Ltd.

TZ Medical

Essential Medical, Inc.

Key strategies include product innovation, regional expansion, and mergers & acquisitions to enhance global presence. For example:

In 2024, Abbott launched its next-gen vascular closure platform with enhanced suture-based technology for complex cases.

Terumo expanded its vascular closure portfolio in 2023 by acquiring a startup focused on bioresorbable devices.

Scope of Work – Global Vascular Closure Device Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.3 billion

CAGR (2023–2031) 8.4%

Market Segments By System Type, By End-Use, By Region

Growth Drivers Rising cardiovascular procedures, minimally invasive preference, tech innovation

Opportunities Emerging markets, ASC growth, novel bioabsorbable products

Key Market Developments:

March 2024 – Medtronic introduced a fully automated vascular closure device with AI-guided deployment for consistent performance.

July 2023 – Cardinal Health entered into a distribution partnership with a European startup specializing in extravascular closure solutions.

October 2022 – Teleflex received FDA approval for its latest radial artery closure device tailored for same-day discharge protocols.

FAQs:

1) What is the current market size of the Global Vascular Closure Device Market?

The market was valued at USD 1.2 billion in 2023.

2) What is the major growth driver of the Global Vascular Closure Device Market?

The major growth driver is the rising volume of cardiovascular procedures and preference for minimally invasive interventions.

3) Which is the largest region during the forecast period in the Global Vascular Closure Device Market?

North America is the largest region, attributed to high procedure volumes and favorable reimbursement.

4) Which segment accounted for the largest market share in Global Vascular Closure Device Market?

The Passive Approximators segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Vascular Closure Device Market?

Key players include Abbott, Terumo, Medtronic, Cardinal Health, Teleflex, and Merit Medical Systems.

Let me know if you’d like this formatted for a brochure, slide deck, or export to a Word document.